03Jan/13

Heart Metabolics Receives Funding for US Clinical Development of Heart … – PharmaLive (press release) (subscription)

Heart Metabolics Receives Funding for US Clinical Development of Heart
PharmaLive (press release) (subscription)
The proceeds of the Series A round will be used to advance U.S. clinical development of the company’s lead drug candidate, perhexiline, for the treatment of heart failure symptoms in patients with hypertrophic cardiomyopathy (“HCM”). Investors in the

and more »

03Jan/13

Heart Metabolics Receives Funding for US Clinical Development of Heart … – PharmaLive.com (press release)

Heart Metabolics Receives Funding for US Clinical Development of Heart
PharmaLive.com (press release)
The proceeds of the Series A round will be used to advance U.S. clinical development of the company’s lead drug candidate, perhexiline, for the treatment of heart failure symptoms in patients with hypertrophic cardiomyopathy (“HCM”). Investors in the

and more »

03Jan/13

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart … – PR Newswire (press release)

Heart Metabolics Receives Funding for U.S. Clinical Development of Heart
PR Newswire (press release)
The proceeds of the Series A round will be used to advance U.S. clinical development of the company’s lead drug candidate, perhexiline, for the treatment of heart failure symptoms in patients with hypertrophic cardiomyopathy (“HCM”). Investors in the

and more »